Neural tube defects, large heads and hydrocephalus

17.4 Neural tube defects, large heads and hydrocephalus




Neural tube defects


The neural tube is the embryological structure from which the brain and spinal cord develop. The term neural tube defect (NTD) refers to a group of malformations involving the brain and/or spinal cord in association with varying degrees of absence or malformation of the overlying tissues: meninges, bone, muscle and skin. Anencephaly occurs when the neural tube fails to close at the head, and the brain and skull bones do not develop normally. Myelomeningocele (myelo meaning ‘cord’; meninges, coverings of the spinal cord; cele, ‘sac’) involves all the tissue layers including the skin and bone, and is an outpouching of the spinal cord through the posterior bony vertebral column that has failed to form. Meningocele is an outpouching of the meninges or coverings of the spinal cord only, and not the cord itself. The term spina bifida refers to the normal bony projection over the spine being divided or ‘bifid’. Spina bifida occulta is the failure of the formation of the posterior elements of the vertebrae but without any outpouching of the meninges or spinal cord. It occurs in 5–10% of the population and is most often asymptomatic. X-rays of the spine documenting the incomplete vertebral arch confirm the diagnosis. Accompanying associated features may include dermal hyperpigmentation, a fatty swelling, a tuft of hair or a dermal sinus on the back. Spina bifida cystica refers to myelomeningocele and meningocele. Myelomeningocele is the more serious and commoner type of spina bifida cystica. Spinal dysraphism, which includes spina bifida occulta, meningocele and myelomeningocele, is part of the family of NTDs that encompasses abnormalities of the cranium and its contents (anencephaly, encephalocele and cranial meningocele) as well as abnormalities of the spine.





Antenatal diagnosis, antenatal counselling and fetal surgery


The presence of abnormally high levels of AFP in the amniotic fluid has a high correlation with myelomeningocele. AFP is a component of fetal cerebrospinal fluid (CSF) and it probably leaks into the amniotic fluid from the open NTD. Closed lesions often do not cause increased AFP levels. The false-positive rate for the determination of myelomeningocele is less than 0.5% and the false-negative rate is 2%. AFP is synthesized by the yolk sac, hepatic cells and gastrointestinal tract of the fetus and is normally excreted in the amniotic fluid in fetal urine. The detection rate for open NTDs using maternal serum screening is approximately 80%, with a low false-positive rate. Ultrasonography can detect or confirm the extent of the NTD.


Offering counselling for the family with an antenatal diagnosis of a NTD is important, especially as the family will probably consider their options about whether to continue with the pregnancy or elect for termination. Great care should be taken about the information conveyed. Preferably, it should be given by a specialist experienced in caring for children with a NTD, in an appropriate environment and with time available to answer the family’s questions about all the facets of raising a child with this diagnosis. The antenatal scan can offer some guidance, but it must be remembered that ultrasound scan findings cannot predict all aspects of functioning (physical and cognitive) accurately. In addition, families can be offered further counselling through community-based organizations (e.g. the Spina Bifida and Hydrocephalus Association). All families should be made aware of preventative measures (periconceptional folate) and offered genetic counselling if they wish to have other children in the future.


Fetal surgery (for closure of the myelomeningocele lesion) at 20–30 weeks’ gestation, after which the fetus is returned to the uterus, has been developed with the hope of preventing significant complications in the affected child. Early studies have demonstrated good cosmetic closure of the lesion but the complication rate (primarily due to the fetus being delivered prematurely) was found to be high. The primary outcome is a significant reduction of the development of hydrocephalus in the treatment group.



Clinical features


NTDs may be classified as in Box 17.4.1.



Box 17.4.1 Classification of neural tube defects












Management of myelomeningocele


A team approach that includes the parents is essential for the proper management of myelomeningocele. An important factor, which compounds the disability, is that the defect is apparent at birth. Information given to the parents and the manner in which it is conveyed will influence their reaction at this most vulnerable time and will affect the future of the child and the family. Medical specialists in this team include the neurosurgeon, orthopaedic surgeon and urologist. The medical team leader is most appropriately a paediatrician or paediatric rehabilitation specialist with special skills in the field of child development and rehabilitation. The medical team leader will coordinate care but, importantly, will also manage and advise on the multiple problems experienced by the children and their families. These include disability issues, school integration, interventions to improve functional outcome, and various activities to support the parents and child through the many problems, both physical and psychological, that invariably arise. The physiotherapist, occupational therapist, speech pathologist, dietitian, orthotist, psychologist and medical social worker, together with trained hospital and community-based nursing staff and teachers, are important members of this team. The team has three major goals:




Specific problems in the management of the newborn with spina bifida


It is possible to predict with considerable accuracy the potential for future impairment in a number of areas. These include ambulation and subsequent mobility, probable bowel and bladder function, and hydrocephalus, with its probable sequelae. It is much more difficult to predict the effects that these impairments will have on the lifestyle of the individual and family. Also, it is possible to recognize early those lesions that are inoperable because of massive bony deformity and extensive skin loss, which would prevent closure of the defect. The specific problems are as follows:




Ongoing management







Stay updated, free articles. Join our Telegram channel

Aug 4, 2016 | Posted by in PEDIATRICS | Comments Off on Neural tube defects, large heads and hydrocephalus

Full access? Get Clinical Tree

Get Clinical Tree app for offline access